Home | Cancers


A conversation with a cancer patient about palliative care

Palliative care expert Timothy Quill held an intimate conversation with a Stanford neurosurgeon suffering from advanced lung cancer as an example of ...

Highly effective new anti-cancer drug shows few side effects—in mice

As injections or pills, drug inhibits an enzyme active in many cancer types ...

Research Study of Personalized Cellular Therapy Achieves Complete Remission in 90 Percent of Acute Lymphoblastic Leukemia Patients Studied

University of Pennsylvania and Children's Hospital of Philadelphia Studies Reveal Unprecedented Results with Investigational Therapy Made From Patients' Own Immune Cells ... Full story

Early Palliative Care Can Cut Hospital Readmissions for Cancer Patients

By Duke Medicine News and Communications - DURHAM, N.C. -- Doctors at Duke University Hospital have developed a new collaborative model in cancer care that reduced the rates at which patients were sent to intensive care or readmitted to the hospital after discharge. ... Full story

Fast modeling of cancer mutations

New genome-editing technique enables rapid analysis of genes mutated in tumors. ... Full story

New study identifies potential targets for personalized cancer vaccines

A team of University of Notre Dame scientists, in collaboration with researchers at the University of Connecticut, have announced the results of a new study on identifying potential targets for personalized cancer vaccines. ... Full story

Highly effective new anti-cancer drug shows few side effects in mice

As injections or pills, drug inhibits an enzyme that is active in many cancer types ... Full story

‘Designer’ nanodevice could improve treatment options for cancer sufferers

Cancer diagnostics and treatment options could be drastically improved with the creation of a ‘designer’ nanodevice being developed by researchers from the UK, Italy, the US and Argentina. ... Full story

Colon cancer: Two genetic alterations that generate metastases

With approximately 42,000 estimated new cases in France in 2012, colon cancer is, for both sexes combined, the third most common type of cancer, and the second most common cause of cancer deaths after lung cancer. One of the challenges is to succeed in treating the cancer when metastases are present. Researchers at Institut Curie, Inserm and CNRS describe—theoretically and experimentally—in the journal Nature Communications, the combination of two genetic alterations responsible for tumour dissemination. As well as contributing knowledge on tumour progression, the cancer colon model thus developed offers the possibility of testing new therapies for eliminating metastases. ... Full story

1 2 3 4 5 6 7 8 9 10 next last total: 6796 | displaying: 1 - 10